Trial Profile
Clinical Trials Insight: 700035649
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Jun 2011
Price :
$35
*
At a glance
- Drugs Teverelix (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors Ardana plc
- 24 Jul 2008 New trial record.